Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

about

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

Item

http://www.wikidata.org/entity/Q57483192

description

article

@en

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cariprazine for acute and main ...... ed review and place in therapy

@en

Cariprazine for acute and main ...... ed review and place in therapy

@nl

type

Item

label

Cariprazine for acute and main ...... ed review and place in therapy

@en

Cariprazine for acute and main ...... ed review and place in therapy

@nl

prefLabel

Cariprazine for acute and main ...... ed review and place in therapy

@en

Cariprazine for acute and main ...... ed review and place in therapy

@nl

P1476

Cariprazine for acute and main ...... ed review and place in therapy

@en

P2860

Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography

Schizophrenia relapse, patient considerations, and potential role of lurasidone

Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics.

Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.

Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.

Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents.

On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not.

Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors.

P304

2563-2577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S159704

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leslie Citrome

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323605

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

6179724

http://www.w3.org/2001/XMLSchema#string